Cepharanthine
Drug profile
Also known as: cepharanthin
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Cepharanthine is a drug catalogued in DrugCentral. It was first approved by the PMDA in 1951. DrugCentral lists 6 molecular targets, including REP, KCNN3 and KCNN2. Recorded indications include Alopecia, Aptyalism, Leukopenia and Snake bite - wound.
- Molecular targets: REP, KCNN3, KCNN2 and TPR (6 listed in DrugCentral).
- Indications: Alopecia, Aptyalism, Leukopenia and Snake bite - wound.
- Molecular formula: C37H38N2O6; molecular weight 606.72 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (4)
- Alopecia
- Aptyalism
- Leukopenia
- Snake bite - wound
Off-label uses (1)
- Coronavirus infection
Mechanism & targets
Molecular targets (6)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Replicase polyprotein 1ab | REP | unknown | IC50 7.00 |
| Small conductance calcium-activated potassium channel protein 3 | KCNN3 | unknown | Ki 5.96 |
| Small conductance calcium-activated potassium channel protein 2 | KCNN2 | unknown | Ki 5.88 |
| Trypanothione reductase | TPR | unknown | Ki 5.12 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | PRKAA1 | inhibitor | — |
| Nuclear factor NF-kappa-B p105 subunit | NFKB1 | inhibitor | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1951-01-01 | PMDA | — | — |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Cepharanthine is on its molecule page.
| Molecular formula | C37H38N2O6 |
|---|---|
| Molecular weight | 606.72 g/mol |
| CAS number | 481-49-2 |
| InChIKey | YVPXVXANRNDGTA-WDYNHAJCSA-N |
| PubChem CID | 10206 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Cepharanthine used for?
DrugCentral lists the following indications for Cepharanthine: Alopecia, Aptyalism, Leukopenia and Snake bite - wound.
How does Cepharanthine work?
Its molecular targets in DrugCentral include REP, KCNN3, KCNN2 and TPR.
When was Cepharanthine first approved?
Cepharanthine was first approved by the PMDA in 1951.
What is the chemical formula of Cepharanthine?
Cepharanthine has the molecular formula C37H38N2O6 and a molecular weight of 606.72 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5375 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2074948 — compound record and bioactivity
- PubChem CID 10206 — chemical identifiers
- DrugBank DB16824 — drug record
- FDA UNII 7592YJ0J6T — substance identity
- UniProt Q9UGI6 (KCNN3) — target protein
- UniProt Q9H2S1 (KCNN2) — target protein
- UniProt Q13131 (PRKAA1) — target protein
- UniProt P19838 (NFKB1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.